## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.
Circulating fatty acids and prostate cancer risk in a nested case–control study: the Multiethnic Cohort
✍ Scribed by Song-Yi Park; Lynne R. Wilkens; Susanne M. Henning; Loïc Le Marchand; Kun Gao; Marc T. Goodman; Suzanne P. Murphy; Brian E. Henderson; Laurence N. Kolonel
- Publisher
- Springer Netherlands
- Year
- 2008
- Tongue
- English
- Weight
- 207 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con
Smoking is the only generally accepted risk factor for pancreatic cancer. Reproductive history has in recent studies been associated with pancreatic cancer, but with contradictory results. In order to evaluate a possible association between age at first birth and the number of births and pancreatic
A case-control study of prostate cancer (PC) was undertaken in Athens, Greece. Cases were 320 patients with histologically confirmed incident disease, whereas controls were 246 patients without history or symptomatology of benign prostatic hyperplasia, treated in the same hospitals as the cases for
The relationship between frequency of intake of different types of fat and breast cancer was investigated in a case-control study conducted in Montevideo, Uruguay, during the time period 1994-1996. Our study comprised 365 cases and 397 controls. A moderate and non-significant increase in risk of bre